Invention Grant
- Patent Title: Tetracyclic heteroaryl compounds
-
Application No.: US17053400Application Date: 2019-05-07
-
Publication No.: US11407765B2Publication Date: 2022-08-09
- Inventor: Jason Grant Kettle , Sharanjeet Kaur Bagal , Andrew John Eatherton , Shaun Michael Fillery , Graeme Richard Robb , Scott Gibson Lamont , Paul David Kemmitt , Frederick Woolf Goldberg
- Applicant: AstraZeneca AB
- Applicant Address: SE Södertälje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Södertälje
- International Application: PCT/EP2019/061754 WO 20190507
- International Announcement: WO2019/215203 WO 20191114
- Main IPC: C07D498/14
- IPC: C07D498/14
Abstract:
The specification relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof. The specification also relates to processes and intermediates used for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.
Public/Granted literature
- US20210221823A1 TETRACYCLIC HETEROARYL COMPOUNDS Public/Granted day:2021-07-22
Information query
